Drugs for overactive bladder, type 2 diabetes and preventing blood clots have been approved for use by the NHS in England and Wales.
The National Institute for Health and Care Excellence has recommended mirabegron (Betmiga) as an option for treating the symptoms of overactive bladder and also rivaroxaban (Xarelto) as an option for treating pulmonary embolism and preventing recurrent deep vein thrombosis and PE.
Meanwhile, in a further technology appraisal, NICE said dapagliflozin (Forxiga) was recommended as an option for treating type 2 diabetes in combination with metformin or insulin.
Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.